These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 24622513)
41. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome. Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369 [TBL] [Abstract][Full Text] [Related]
42. Medicine. Gene therapy that works. Verma IM Science; 2013 Aug; 341(6148):853-5. PubMed ID: 23970689 [No Abstract] [Full Text] [Related]
43. Development of lentiviral gene therapy for Wiskott Aldrich syndrome. Galy A; Roncarolo MG; Thrasher AJ Expert Opin Biol Ther; 2008 Feb; 8(2):181-90. PubMed ID: 18194074 [TBL] [Abstract][Full Text] [Related]
44. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome. Candotti F J Clin Immunol; 2018 Jan; 38(1):13-27. PubMed ID: 29086100 [TBL] [Abstract][Full Text] [Related]
45. Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma. Tavil B; Erdem AY; Azik F; Isik P; Metin A; Emir S; Uckan D; Tunc B Pediatr Transplant; 2013 Sep; 17(6):E146-8. PubMed ID: 23773507 [TBL] [Abstract][Full Text] [Related]
46. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size. Patel PD; Samanich JM; Mitchell WB; Manwani D Pediatr Blood Cancer; 2011 Jul; 56(7):1127-9. PubMed ID: 21488158 [TBL] [Abstract][Full Text] [Related]
47. Wiskott-Aldrich syndrome: a comprehensive review. Massaad MJ; Ramesh N; Geha RS Ann N Y Acad Sci; 2013 May; 1285():26-43. PubMed ID: 23527602 [TBL] [Abstract][Full Text] [Related]
48. Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cells. Andreu N; Aran JM; Fillat C Int J Mol Med; 2007 Oct; 20(4):445-50. PubMed ID: 17786274 [TBL] [Abstract][Full Text] [Related]
49. WASP and the phenotypic range associated with deficiency. Notarangelo LD; Notarangelo LD; Ochs HD Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):485-90. PubMed ID: 16264326 [TBL] [Abstract][Full Text] [Related]
50. Gene therapy of primary T cell immunodeficiencies. Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799 [TBL] [Abstract][Full Text] [Related]
51. Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome. Magnani A; Semeraro M; Adam F; Booth C; Dupré L; Morris EC; Gabrion A; Roudaut C; Borgel D; Toubert A; Clave E; Abdo C; Gorochov G; Petermann R; Guiot M; Miyara M; Moshous D; Magrin E; Denis A; Suarez F; Lagresle C; Roche AM; Everett J; Trinquand A; Guisset M; Bayford JX; Hacein-Bey-Abina S; Kauskot A; Elfeky R; Rivat C; Abbas S; Gaspar HB; Macintyre E; Picard C; Bushman FD; Galy A; Fischer A; Six E; Thrasher AJ; Cavazzana M Nat Med; 2022 Jan; 28(1):71-80. PubMed ID: 35075289 [TBL] [Abstract][Full Text] [Related]